| 序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
| 1 |
1950635-14-9 |
Thalidomide-O-amido-C6-NH2(TFA) |
|
|
询价 |
| 2 |
1799711-25-3 |
Thalidomide-O-amido-C4-NH2(TFA)(Cereblon Ligand-Linker Conjugates 6(TFA)) |
|
|
询价 |
| 3 |
2098488-36-7 |
Thalidomide-O-amido-C4-N3 |
|
|
询价 |
| 4 |
2308035-51-8 |
Thalidomide-O-amido-C3-COOH |
|
|
询价 |
| 5 |
1818885-63-0 |
Pomalidomide-PEG4-Ph-NH2 |
|
|
询价 |
| 6 |
2225940-52-1 |
Pomalidomide-PEG4-C2-NH2 |
|
|
询价 |
| 7 |
2097938-44-6 |
Pomalidomide-PEG4-C-COOH |
|
|
询价 |
| 8 |
|
Pomalidomide-PEG3-C2-NH2(TFA) |
|
100mg |
询价 |
| 9 |
2305369-00-8 |
Pomalidomide-C2-NH2 hydrochloride |
|
|
询价 |
| 10 |
2098836-50-9 |
AT6 |
|
|
询价 |
| 11 |
1835705-59-3 |
(S,R,S)-AHPC-PEG6-C4-Cl(VH032-PEG6-C4-Cl) |
|
|
询价 |
| 12 |
2064292-52-8 |
(S,R,S)-AHPC-PEG4-NH2 hydrochloride(VH032-PEG4-NH2 hydrochloride) |
|
|
询价 |
| 13 |
2010159-57-4 |
(S,R,S)-AHPC-PEG4-NH2(VH032-PEG4-NH2) |
|
|
询价 |
| 14 |
1797406-81-5 |
(S,R,S)-AHPC-PEG4-N3(VH032-PEG4-N3) |
|
|
询价 |
| 15 |
2097971-11-2 |
(S,R,S)-AHPC-PEG3-NH2 hydrochloride(VH032-PEG3-NH2 hydrochloride) |
|
|
询价 |
| 16 |
1797406-80-4 |
(S,R,S)-AHPC-PEG3-N3(VH032-PEG3-N3) |
|
|
询价 |
| 17 |
2097973-72-1 |
(S,R,S)-AHPC-PEG2-NH2 hydrochloride(VH032-PEG2-NH2 hydrochloride) |
|
|
询价 |
| 18 |
2010159-45-0 |
(S,R,S)-AHPC-PEG2-N3(VH032-PEG2-N3) |
|
|
询价 |
| 19 |
1835705-57-1 |
(S,R,S)-AHPC-PEG2-C4-Cl(VH032-PEG2-C4-Cl) |
|
|
询价 |
| 20 |
2101200-09-1 |
(S,R,S)-AHPC-PEG1-N3(VH032-PEG1-N3) |
|
|
询价 |
| 21 |
1948273-03-7 |
(S,R,S)-AHPC-Me hydrochloride |
|
|
询价 |
| 22 |
2138861-99-9 |
ABBV-744 |
|
|
询价 |
| 23 |
|
(S,R,S)-AHPC-Me dihydrochloride |
|
|
询价 |
| 24 |
1835705-55-9 |
(S,R,S)-AHPC-C6-PEG3-C4-Cl(VH032-C6-PEG3-C4-Cl) |
|
|
询价 |
| 25 |
2245697-83-8 |
(S,R,S)-AHPC-C3-NH2(VH032-C3-NH2) |
|
|
询价 |
| 26 |
1835705-61-7 |
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl |
|
|
询价 |
| 27 |
1448189-80-7 |
(S,R,S)-AHPC hydrochloride(MDK7526 hydrochlorideVH032-NH2 hydrochloride) |
|
|
询价 |
| 28 |
13408-09-8 |
β-Glycerol phosphate disodium salt pentahydrate [CAS 13408-09-8] |
|
|
询价 |
| 29 |
476310-60-8 |
VO-Ohpic trihydrate(VO-Ohpic) |
|
|
询价 |
| 30 |
844499-71-4 |
A-769662 |
|
|
询价 |
| 31 |
345630-40-2 |
SF1670(PTPase CD45 Inhibitor) |
|
|
询价 |
| 32 |
371942-69-7 |
YM-201636 |
|
|
询价 |
| 33 |
900874-91-1 |
T-00127_HEV1 |
|
|
询价 |
| 34 |
593960-11-3 |
PIK-93 |
|
|
询价 |
| 35 |
1429624-84-9 |
PI4KIIIbeta inhibitor 9 |
|
|
询价 |
| 36 |
1245319-54-3 |
PI4KIII beta inhibitor 3 |
|
|
询价 |
| 37 |
1610610-48-4 |
KDU731 |
|
|
询价 |
| 38 |
1889279-16-6 |
A-485 |
|
|
询价 |
| 39 |
1527503-11-2 |
A-366 |
|
|
询价 |
| 40 |
1433286-70-4 |
666-15 |
|
|
询价 |
| 41 |
1621-56-3 |
7-Methoxyisoflavone |
|
100mg |
询价 |
| 42 |
5189-11-7 |
Pizotifen Malate |
|
100mg, 200mg |
询价 |
| 43 |
72496-41-4 |
Pirarubicin |
|
10mg, 50mg, 100mg |
询价 |
| 44 |
28721-07-5 |
Oxcarbazepine |
|
10mg, 50mg |
询价 |
| 45 |
838-07-3 |
5-Methyl-2'-deoxycytidine |
|
100mg |
询价 |
| 46 |
120964-45-6 |
3-Deazaneplanocin A hydrochloride(DZNep HClNSC 617989 HCl3-Deazaneplanocin HCl) |
|
|
询价 |
| 47 |
102052-95-9 |
3-Deazaneplanocin A(NSC 6179893-DeazaneplanocinDZNep) |
|
|
询价 |
| 48 |
1349719-98-7 |
(S)-JQ-35(TEN-010) |
|
|
询价 |
| 49 |
1268524-71-5 |
(R)-(-)-JQ1 Enantiomer |
|
|
询价 |
| 50 |
1092578-47-6 |
(3S,4S)-Tofacitinib |
|
|
询价 |
| 51 |
1092578-48-7 |
(3S,4R)-Tofacitinib |
|
|
询价 |
| 52 |
1092578-46-5 |
(3R,4S)-Tofacitinib |
|
5mg |
询价 |
| 53 |
90365-57-4 |
(-)-Indolactam V(Indolactam V) |
|
5mg |
询价 |
| 54 |
2115701-93-2 |
(+)-JQ1 PA |
|
|
询价 |
| 55 |
1268524-70-4 |
(+)-JQ-1(JQ1) |
|
|
询价 |
| 56 |
873697-71-3 |
Omecamtiv mecarbil(CK-1827452) |
|
|
询价 |
| 57 |
224579-74-2 |
MLCK inhibitor peptide 18 |
|
|
询价 |
| 58 |
110448-33-4 |
ML-7 hydrochloride |
|
|
询价 |
| 59 |
1642288-47-8 |
Mavacamten(MYK461SAR439152) |
|
|
询价 |
| 60 |
84468-24-6 |
HA-100 |
|
|
询价 |
m.cnreagent.com
